RxDoctor Payments DataLook up a doctor →

Rony Ninan, MD

Clinical Neurophysiology · Pearland, TXNPI 1750526182

Payments from drug & device makers

$15,576in general payments, 2019–2025

Across 413 payments — averaging $37.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$8K
  • AbbVie$1K
  • Novartis$610
  • Amgen$533
  • Acorda Therapeutics, Inc$505
  • Acadia Pharmaceuticals Inc$349
  • plus $4K from 43 others

What the payments were for

  • Speaking & faculty fees$4713%
  • Food & beverage$15,10597%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,576 in reported general payments places this provider in the 75th percentile of 50 clinical neurophysiology providers in Texas.

See all clinical neurophysiology providers in Texas

Medicare billing

Part B allowed, 2024
$24,946
Medicare patients
115
Services billed
296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam15$303
Diclofenac Potassium13$184
Nortriptyline Hcl13$176
Gabapentin14$109
Donepezil Hcl11$26

Paid to pharmacies, not to this prescriber.

Other clinical neurophysiology in Pearland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →